메뉴 건너뛰기




Volumn 32, Issue 2, 2010, Pages 238-245

Combination of adoptive cell transfer and antibody injection can eradicate established tumors in MiceAn in vivo study using anti-OX40mAb, anti-CD25mAb and anti-CTLA4mAb

Author keywords

CD25; CTLA4; OX40; Tumor Immunology; Tumor rejection

Indexed keywords

3 METHYLCHOLANTHRENE; BASILIXIMAB; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 ANTIBODY; INTERLEUKIN 2 RECEPTOR ALPHA; OX40 LIGAND; TRANSCRIPTION FACTOR FOXP3;

EID: 77952162673     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.3109/08923970903222355     Document Type: Article
Times cited : (8)

References (39)
  • 3
    • 33748987908 scopus 로고    scopus 로고
    • Cancer despite immunosurveillance: Immunoselection and immunosubversion
    • Zitvogel L, Tesniere A, Kroemer G. Cancer despite immunosurveillance: immunoselection and immunosubversion. Nat Rev Immunol 2006;6:715-727
    • (2006) Nat Rev Immunol , vol.6 , pp. 715-727
    • Zitvogel, L.1    Tesniere, A.2    Kroemer, G.3
  • 4
    • 0031091743 scopus 로고    scopus 로고
    • Is CTLA-4 a master switch for peripheral T cell tolerance?
    • Bluestone JA. Is CTLA-4 a master switch for peripheral T cell tolerance? J Immunol 1997;158:1989-1993
    • (1997) J Immunol , vol.158 , pp. 1989-1993
    • Bluestone, J.A.1
  • 5
    • 0034679567 scopus 로고    scopus 로고
    • Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+) CD4(+) regulatory cells that control intestinal inflammation
    • Read S, Malmstrom V, Powrie F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+) CD4(+) regulatory cells that control intestinal inflammation. J Exp Med 2000;192:295-302.
    • (2000) J Exp Med , vol.192 , pp. 295-302
    • Read, S.1    Malmstrom, V.2    Powrie, F.3
  • 6
    • 33749132564 scopus 로고    scopus 로고
    • Blockade of CTLA-4 on CD4+CD25+ regulatory T cells abrogates their function in vivo
    • Read S, Greenwald R, Izcue A, Robinson N, Mandelbrot D, Francisco L et al. Blockade of CTLA-4 on CD4+CD25+ regulatory T cells abrogates their function in vivo. J Immunol 2006;177:4376-4383
    • (2006) J Immunol , vol.177 , pp. 4376-4383
    • Read, S.1    Greenwald, R.2    Izcue, A.3    Robinson, N.4    Mandelbrot, D.5    Francisco, L.6
  • 7
    • 49649113444 scopus 로고    scopus 로고
    • Acquisition of suppressive function by activated human CD4+ CD25- T cells is associated with the expression of CTLA-4 not FoxP3
    • Zheng Y, Manzotti CN, Burke F, Dussably L, Qureshi O, Walker LS et al. Acquisition of suppressive function by activated human CD4+ CD25- T cells is associated with the expression of CTLA-4 not FoxP3. J Immunol 2008;181:1683-1691
    • (2008) J Immunol , vol.181 , pp. 1683-1691
    • Zheng, Y.1    Manzotti, C.N.2    Burke, F.3    Dussably, L.4    Qureshi, O.5    Walker, L.S.6
  • 8
    • 0033168037 scopus 로고    scopus 로고
    • Tumor rejection by in vivo administration of anti-CD25 (interleukin- 2 receptor alpha) monoclonal antibody
    • Onizuka S, Tawara I, Shimizu J, Sakaguchi S, Fujita T, Nakayama E. Tumor rejection by in vivo administration of anti-CD25 (interleukin- 2 receptor alpha) monoclonal antibody. Cancer Res 1999;59:3128-3133
    • (1999) Cancer Res , vol.59 , pp. 3128-3133
    • Onizuka, S.1    Tawara, I.2    Shimizu, J.3    Sakaguchi, S.4    Fujita, T.5    Nakayama, E.6
  • 9
    • 0029947568 scopus 로고    scopus 로고
    • Enhancement of antitumor immunity by CTLA-4 blockade
    • Leach DR, Krummel MF, Allison JP. Enhancement of antitumor immunity by CTLA-4 blockade. Science 1996;271:1734-1736
    • (1996) Science , vol.271 , pp. 1734-1736
    • Leach, D.R.1    Krummel, M.F.2    Allison, J.P.3
  • 10
    • 0025320534 scopus 로고
    • Characterization of the MRC OX40 antigen of activated CD4 positive T lymphocytes -a molecule related to nerve growth factor receptor
    • Mallett S, Fossum S, Barclay AN. Characterization of the MRC OX40 antigen of activated CD4 positive T lymphocytes -a molecule related to nerve growth factor receptor. Embo J 1990;9:1063-1068
    • (1990) Embo J , vol.9 , pp. 1063-1068
    • Mallett, S.1    Fossum, S.2    Barclay, A.N.3
  • 11
    • 0029812623 scopus 로고    scopus 로고
    • OX40 is differentially expressed on activated rat and mouse T cells and is the sole receptor for the OX40 ligand
    • al-Shamkhani A, Birkeland ML, Puklavec M, Brown MH, James W, Barclay AN. OX40 is differentially expressed on activated rat and mouse T cells and is the sole receptor for the OX40 ligand. Eur J Immunol 1996;26:1695-1699
    • (1996) Eur J Immunol , vol.26 , pp. 1695-1699
    • Al-Shamkhani, A.1    Birkeland, M.L.2    Puklavec, M.3    Brown, M.H.4    James, W.5    Barclay, A.N.6
  • 12
    • 0034306979 scopus 로고    scopus 로고
    • Therapeutic efficacy of OX-40 receptor antibody depends on tumor immunogenicity and anatomic site of tumor growth
    • Kjaergaard J, Tanaka J, Kim JA, Rothchild K, Weinberg A, Shu S. Therapeutic efficacy of OX-40 receptor antibody depends on tumor immunogenicity and anatomic site of tumor growth. Cancer Res 2000;60:5514-5521
    • (2000) Cancer Res , vol.60 , pp. 5514-5521
    • Kjaergaard, J.1    Tanaka, J.2    Kim, J.A.3    Rothchild, K.4    Weinberg, A.5    Shu, S.6
  • 14
    • 0017661198 scopus 로고
    • Cell surface antigens of chemically induced sarcomas of the mouse. I. Murine leukemia virus-related antigens and alloantigens on cultured fibroblasts and sarcoma cells: Description of a unique antigen on BALB/c Meth A sarcoma
    • DeLeo AB, Shiku H, Takahashi T, John M, Old LJ. Cell surface antigens of chemically induced sarcomas of the mouse. I. Murine leukemia virus-related antigens and alloantigens on cultured fibroblasts and sarcoma cells: description of a unique antigen on BALB/c Meth A sarcoma. J Exp Med 1977;146:720-734
    • (1977) J Exp Med , vol.146 , pp. 720-734
    • Deleo, A.B.1    Shiku, H.2    Takahashi, T.3    John, M.4    Old, L.J.5
  • 15
    • 34248350754 scopus 로고    scopus 로고
    • Spleen plays an important role in maintaining tolerance after removal of the vascularized heart graft
    • Chosa E, Hara M, Watanabe A, Matsuzaki Y, Nakamura K, Hamano K et al. Spleen plays an important role in maintaining tolerance after removal of the vascularized heart graft. Transplantation 2007;83:1226-1233
    • (2007) Transplantation , vol.83 , pp. 1226-1233
    • Chosa, E.1    Hara, M.2    Watanabe, A.3    Matsuzaki, Y.4    Nakamura, K.5    Hamano, K.6
  • 17
    • 34047220868 scopus 로고    scopus 로고
    • Cancer immunoediting from immune surveillance to immune escape
    • Kim R, Emi M, Tanabe K. Cancer immunoediting from immune surveillance to immune escape. Immunology 2007;121:1-14.
    • (2007) Immunology , vol.121 , pp. 1-14
    • Kim, R.1    Emi, M.2    Tanabe, K.3
  • 18
    • 33244472107 scopus 로고    scopus 로고
    • Tumor-infiltrating T lymphocytes: Friends or foes?
    • Yu P, Fu YX. Tumor-infiltrating T lymphocytes: friends or foes? Lab Invest 2006;86:231-245
    • (2006) Lab Invest , vol.86 , pp. 231-245
    • Yu, P.1    Fu, Y.X.2
  • 19
    • 4644237613 scopus 로고    scopus 로고
    • Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
    • Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 2004;10:942-949
    • (2004) Nat Med , vol.10 , pp. 942-949
    • Curiel, T.J.1    Coukos, G.2    Zou, L.3    Alvarez, X.4    Cheng, P.5    Mottram, P.6
  • 20
    • 0029783148 scopus 로고    scopus 로고
    • Protective antitumor immunity induced by immunization with completely allogeneic tumor cells
    • Toes RE, Blom RJ, van der Voort E, Offringa R, Melief CJ, Kast WM. Protective antitumor immunity induced by immunization with completely allogeneic tumor cells. Cancer Res 1996;56:3782-3787
    • (1996) Cancer Res , vol.56 , pp. 3782-3787
    • Toes, R.E.1    Blom, R.J.2    Van Der Voort, E.3    Offringa, R.4    Melief, C.J.5    Kast, W.M.6
  • 21
    • 0031758085 scopus 로고    scopus 로고
    • Peptide vaccination with an anchorreplaced CTL epitope protects against human papillomavirus type 16-induced tumors expressing the wild-type epitope
    • Vierboom MP, Feltkamp MC, Neisig A, Drijfhout JW, ter Schegget J, Neefjes JJ et al. Peptide vaccination with an anchorreplaced CTL epitope protects against human papillomavirus type 16-induced tumors expressing the wild-type epitope. J Immunother 1998;21:399-408.
    • (1998) J Immunother , vol.21 , pp. 399-408
    • Vierboom, M.P.1    Feltkamp, M.C.2    Neisig, A.3    Drijfhout, J.W.4    Ter Schegget, J.5    Neefjes, J.J.6
  • 22
    • 14844334891 scopus 로고    scopus 로고
    • Breaking tolerance in cancer immunotherapy: Time to ACT
    • Overwijk WW. Breaking tolerance in cancer immunotherapy: time to ACT. Curr Opin Immunol 2005;17:187-194
    • (2005) Curr Opin Immunol , vol.17 , pp. 187-194
    • Overwijk, W.W.1
  • 23
    • 1642390941 scopus 로고    scopus 로고
    • Activation requirements for the induction of CD4+CD25+ T cell suppressor function
    • Thornton AM, Piccirillo CA, Shevach EM. Activation requirements for the induction of CD4+CD25+ T cell suppressor function. Eur J Immunol 2004;34:366-376
    • (2004) Eur J Immunol , vol.34 , pp. 366-376
    • Thornton, A.M.1    Piccirillo, C.A.2    Shevach, E.M.3
  • 24
    • 0035421654 scopus 로고    scopus 로고
    • Cutting edge: Control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells
    • Piccirillo CA, Shevach EM. Cutting edge: control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells. J Immunol 2001;167:1137-1140
    • (2001) J Immunol , vol.167 , pp. 1137-1140
    • Piccirillo, C.A.1    Shevach, E.M.2
  • 26
    • 0035892897 scopus 로고    scopus 로고
    • Engagement of OX40 enhances antigen-specific CD4(+) T cell mobilization/memory development and humoral immunity: Comparison of alphaOX-40 with alphaCTLA-4
    • Evans DE, Prell RA, Thalhofer CJ, Hurwitz AA, Weinberg AD. Engagement of OX40 enhances antigen-specific CD4(+) T cell mobilization/memory development and humoral immunity: comparison of alphaOX-40 with alphaCTLA-4. J Immunol 2001;167:6804-6811
    • (2001) J Immunol , vol.167 , pp. 6804-6811
    • Evans, D.E.1    Prell, R.A.2    Thalhofer, C.J.3    Hurwitz, A.A.4    Weinberg, A.D.5
  • 27
    • 0032534582 scopus 로고    scopus 로고
    • Ox-40 ligand: A potent costimulatory molecule for sustaining primary CD4 T cell responses
    • Gramaglia I, Weinberg AD, Lemon M, Croft M. Ox-40 ligand: a potent costimulatory molecule for sustaining primary CD4 T cell responses. J Immunol 1998;161:6510-6517
    • (1998) J Immunol , vol.161 , pp. 6510-6517
    • Gramaglia, I.1    Weinberg, A.D.2    Lemon, M.3    Croft, M.4
  • 29
    • 0348223787 scopus 로고    scopus 로고
    • Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3
    • Chen W, Jin W, Hardegen N, Lei KJ, Li L; Marinos N et al. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003;198:1875-1886
    • (2003) J Exp Med , vol.198 , pp. 1875-1886
    • Chen, W.1    Jin, W.2    Hardegen, N.3    Lei, K.J.4    Li, L.5    Marinos, N.6
  • 30
  • 31
    • 0036597371 scopus 로고    scopus 로고
    • CD4+ CD25+ suppressor T cells: More questions than answers
    • Shevach EM. CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol 2002;2:389-400.
    • (2002) Nat Rev Immunol , vol.2 , pp. 389-400
    • Shevach, E.M.1
  • 33
    • 0036467522 scopus 로고    scopus 로고
    • CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10- dependent immunoregulation of alloresponses
    • Kingsley CI, Karim M, Bushell AR, Wood KJ. CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10- dependent immunoregulation of alloresponses. J Immunol 2002;168:1080-1086
    • (2002) J Immunol , vol.168 , pp. 1080-1086
    • Kingsley, C.I.1    Karim, M.2    Bushell, A.R.3    Wood, K.J.4
  • 34
    • 0022473607 scopus 로고
    • A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes
    • Rosenberg SA, Spiess P, Lafreniere R. A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science 1986;233:1318-1321
    • (1986) Science , vol.233 , pp. 1318-1321
    • Rosenberg, S.A.1    Spiess, P.2    Lafreniere, R.3
  • 35
    • 0020047427 scopus 로고
    • Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells
    • North RJ. Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells. J Exp Med 1982;155:1063-1074
    • (1982) J Exp Med , vol.155 , pp. 1063-1074
    • North, R.J.1
  • 36
    • 55949125601 scopus 로고    scopus 로고
    • Adoptive cell therapy for patients with metastatic melanoma: Evaluation of intensive myeloablative chemoradiation preparative regimens
    • Dudley ME, Yang JC, Sherry R, Hughes MS, Royal R, Kammula U et al. Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens. J Clin Oncol 2008;26:5233-5239
    • (2008) J Clin Oncol , vol.26 , pp. 5233-5239
    • Dudley, M.E.1    Yang, J.C.2    Sherry, R.3    Hughes, M.S.4    Royal, R.5    Kammula, U.6
  • 38
    • 3142782785 scopus 로고    scopus 로고
    • Recombinant immunotoxins for the treatment of haematological malignancies
    • Kreitman RJ. Recombinant immunotoxins for the treatment of haematological malignancies. Expert Opin Biol Ther 2004;4:1115-1128
    • (2004) Expert Opin Biol Ther , vol.4 , pp. 1115-1128
    • Kreitman, R.J.1
  • 39
    • 0035903324 scopus 로고    scopus 로고
    • Synergism of cytotoxic T lymphocyte- associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses
    • Sutmuller RP. van Duivenvoorde LM, van Elsas A, Schumacher TN, Wildenberg ME, Allison JP et al. Synergism of cytotoxic T lymphocyte- associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses. J Exp Med 2001;194:823-832
    • (2001) J Exp Med , vol.194 , pp. 823-832
    • Sutmuller, R.P.1    Van Duivenvoorde, L.M.2    Van Elsas, A.3    Schumacher, T.N.4    Wildenberg, M.E.5    Allison, J.P.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.